Experimental research on the depressant effect of aspirin on Ishikawa adenocarcinoma endometrium cell growth

Int J Gynecol Cancer. 2009 Oct;19(7):1182-5. doi: 10.1111/IGC.0b013e3181a12f91.

Abstract

Objective: : To investigate the effect of aspirin on human Ishikawa adenocarcinoma endometrium cell proliferation and apoptosis and its related mechanism through in vitro experiments.

Methods: : The effects on Ishikawa adenocarcinoma endometrium cell proliferation and cell cycle of aspirin at different intervals and concentrations were determined with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method and flow cytometry; cell morphous change after the effect of aspirin was observed with transmission electron microscope; and the effect of aspirin on B-cell lymphoma/leukemia-x, long (Bcl-xl) proteinum expression was determined with Western blot.

Results: : Aspirin had a significant depressant effect on human Ishikawa adenocarcinoma endometrium cell proliferation, and the effect showed time and dose dependence (P < 0.05). Aspirin-induced cell blockage at G1 phase, elevated cell apoptosis rate, and its effect were related with its concentration (P < 0.05). After treatment, cell volume was reduced, chromatin was seen concentrated and aggregated around the edge of nuclear membrane, and apoptotic body was formed. Aspirin decreased Bcl-xl proteinum expression, and the effect was related with its concentration (P < 0.05).

Conclusions: : Aspirin has a distinct depressant effect on human Ishikawa adenocarcinoma endometrium cell growth, and its effect may be realized by lowering Bcl-xl proteinum expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology*
  • Apoptosis / drug effects
  • Aspirin / pharmacology*
  • Cell Cycle / drug effects
  • Cell Line, Tumor*
  • Cell Proliferation / drug effects*
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects
  • Drug Evaluation, Preclinical
  • Endometrial Neoplasms / metabolism
  • Endometrial Neoplasms / pathology*
  • Female
  • Humans
  • Time Factors
  • bcl-X Protein / metabolism

Substances

  • BCL2L1 protein, human
  • bcl-X Protein
  • Aspirin